Grace Therapeutics, Inc. Capital Reinvestment Ratio
Latest as of December 2012:
0.59x
Grace Therapeutics, Inc. capital reinvestment ratio. Grace Therapeutics, Inc. (GRCE) has a Capital Reinvestment Ratio of 0.59x as of December 2012, meaning it reinvests 1% of its operating cash flow ($136.29K) in capital expenditures ($80.55K). Check GRCE cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
0.59x
Capex / Operating Cash Flow
Operating Cash Flow
$136.29K
USD
Capital Expenditures
$80.55K
USD
Data as of
Dec 2012
Most recent filing
Grace Therapeutics, Inc. Capital Reinvestment Ratio by Year (None–None)
Grace Therapeutics, Inc. capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see Grace Therapeutics, Inc. (GRCE) cash conversion ratio.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow